Literature DB >> 22198959

Organizational factors associated with the use of telehospice.

Paula K Baldwin1, William J McAuley, Joan Van Nostrand.   

Abstract

We investigated organizational factors associated with the use of telehospice (defined as the use of video technology by hospices). The investigation was based on the 2007 National Home and Hospice Care Survey. There were 695 hospice agencies, of which 6% used telehospice. Logistic regression was used to examine the relation between use of hospice and a number of organizational factors. The dependent variable was the use/non-use of video technology in patient monitoring or consultations with professionals. Most of the variables that were significantly associated with the use of telehospice were related to characteristics of the agency director. If the director had at least a Masters degree or had a longer tenure as director of the agency, there was a higher likelihood that the agency used telehospice. If the director was a nurse, the likelihood that telehospice was used was considerably lower. Organizations with inter-agency contracts were less likely to use telehospice. Providing financial, training and organizational support to agencies that recognize the potential benefits of telehospice would probably assist in its future introduction.

Entities:  

Mesh:

Year:  2011        PMID: 22198959     DOI: 10.1258/jtt.2011.110803

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  2 in total

1.  Use of information technology for medication management in residential care facilities: correlates of facility characteristics.

Authors:  Soumitra S Bhuyan; Aastha Chandak; M Paige Powell; Jungyoon Kim; Olayinka Shiyanbola; He Zhu; Oyewale Shiyanbola
Journal:  J Med Syst       Date:  2015-05-14       Impact factor: 4.460

2.  Using telehealth to support end of life care in the community: a feasibility study.

Authors:  Jennifer J Tieman; Kate Swetenham; Deidre D Morgan; Timothy H To; David C Currow
Journal:  BMC Palliat Care       Date:  2016-11-17       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.